COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 2067: Articles 20661-20670  | Next

Threatening second wave of COVID-19 is imminent: A deep learning perspective
Nabi, K. N.
10.1101/2020.11.28.20240259 — Posted: 2020-11-30
Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology
LaTurner, Z. W., Zong, D. M., Kalvapalle, P., ReyesGamas, K., Terwilliger, A., Crosby, T., Ali, P., Avadhanula, V., Hernandez Santos, H., Weesner, K., Hopkins, L., Piedra, P. A., Maresso, A., Stadler, L.
10.1101/2020.11.27.20238980 — Posted: 2020-11-30
The impact of vaccination on COVID-19 outbreaks in the United States
Moghadas, S. M., Vilches, T. N., Zhang, K., Wells, C. R., Shoukat, A., Singer, B. H., Meyers, L. A., Neuzil, K. M., Langley, J. M., Fitzpatrick, M. C., Galvani, A. P.
10.1101/2020.11.27.20240051 — Posted: 2020-11-30 Discussion: Onsite
Title: Immunity status of Health Care Workers post recovery from COVID-19: An online longitudinal panel survey
Shah, S. B., Chawla, R., Pahade, A., Bansal, N., Mehta, A., Dewan, A. K., Parkash, A., Bhatia, M.
10.1101/2020.11.27.20239426 — Posted: 2020-11-30
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay
Irsara, C., Egger, A. E., Prokop, W., Nairz, M., Loacker, L., Sahanic, S., Sonnweber, T., Mayer, W., Schennach, H., Loeffler-Ragg, J., Bellmann-Weiler, R., Tancevski, I., Weiss, G., Anliker, M., Griesmacher, A., Hoermann, G.
10.1101/2020.11.27.20239590 — Posted: 2020-11-30
Saliva, a relevant alternative sample for SARS-CoV2 detection
Melo Costa, M., Benoit, N., Dormoi, J., Amalvict, R., Gomez, N., Tissot-Dupont, H., Million, M., Pradines, B., Granjeaud, S., ALMERAS, L.
10.1101/2020.11.27.20239608 — Posted: 2020-11-30
Evaluation of the accuracy and ease-of-use of Abbott PanBio - A WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2
Krüger, L. J., Gaeddert, M., Tobian, F., Lainati, F., Klein, J. A. F., Schnitzler, P., Kräusslich, H.-G., Nikolai, O., Lindner, A. K., Mockenhaupt, F. P., Seybold, J., Corman, V. M., Drosten, C., Pollock, N. R., Knorr, B., Welker, A., de Vos, M., Sacks, J., Denkinger, C. M.
10.1101/2020.11.27.20239699 — Posted: 2020-11-30
Proteo-genomic analysis of SARS-CoV-2: A clinical landscape of SNPs, COVID-19 proteome and host responses
Tushir, S., Kamanna, S., Nath, S. S., Bhat, A., Rose, S., Aithal, A. R., Tatu, U.
10.1101/2020.11.27.20237032 — Posted: 2020-11-30
Predicting critical illness on initial diagnosis of COVID-19: Development and validation of the PRIORITY model for outpatient applicability.
Martinez-Lacalzada, M., Viteri-Noel, A., Manzano, L., Fabregate-Fuente, M., Rubio-Rivas, M., Luis Garcia, S., Arnalich Fernandez, F., Beato Perez, J. L., Calvo Manuel, E., Constanza Espino, A., Freire Castro, S. J., Loureiro-Amigo, J., Pesqueira Fontan, M., Pina, A., Alvarez Suarez, A. M., Silva Asiain, A., Garcia Lopez, B., Luque del Pino, J., Sanz Canovas, J., Chazarra Perez, P., Garcia Garcia, G. M., Millan Nunez-Cortes, J., Casas Rojo, J. M., Gomez Huelgas, R.
10.1101/2020.11.27.20237966 — Posted: 2020-11-30
The possible beneficial role of the regular use of potent mouthwash solutions in the treatment of COVID-19
Mukhtar, K., Qassim, S., Danjuma, I.-M., Babiker, M. E., Mohamedali, M., Alfarhan, H., El-Tayeh, A. R., Fakhri Khudhair, M., Al.Maslamani, M., Al-Dosari, M., Mohamed Elmustafa, R., Hassib, A., Elhadary, W., Abdulkarim, M., Singh, R.
10.1101/2020.11.27.20234997 — Posted: 2020-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).